146 related articles for article (PubMed ID: 29069848)
1. Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis.
Li S; Yang H; Guo P; Ao X; Wan J; Li Q; Tan L
Oncotarget; 2017 Sep; 8(42):73050-73062. PubMed ID: 29069848
[TBL] [Abstract][Full Text] [Related]
2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Habashy D; Hodson E; Craig J
Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a Bayesian network meta-analysis of randomized controlled studies.
Jiang X; Shen W; Xu X; Shen X; Li Y; He Q
Clin Exp Nephrol; 2018 Jun; 22(3):562-569. PubMed ID: 29080118
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
Li HY; Zhang X; Zhou T; Zhong Z; Zhong H
BMC Nephrol; 2019 Oct; 20(1):384. PubMed ID: 31646979
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.
Tan L; Li S; Yang H; Zou Q; Wan J; Li Q
Medicine (Baltimore); 2019 May; 98(22):e15927. PubMed ID: 31145359
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
[TBL] [Abstract][Full Text] [Related]
9. Non-corticosteroid treatment for nephrotic syndrome in children.
Hodson EM; Willis NS; Craig JC
Cochrane Database Syst Rev; 2008 Jan; (1):CD002290. PubMed ID: 18254005
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
Moudgil A; Bagga A; Jordan SC
Pediatr Nephrol; 2005 Oct; 20(10):1376-81. PubMed ID: 15977023
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of cyclosporine A in treatment of refractory nephrotic syndrome in children: a systematic review of randomized controlled trials].
Chen LZ; Jiang XY; Lu HY; Zhang QL; Mo Y
Zhonghua Er Ke Za Zhi; 2009 Dec; 47(12):898-903. PubMed ID: 20193140
[TBL] [Abstract][Full Text] [Related]
12. Interventions for steroid-resistant nephrotic syndrome: a systematic review.
Habashy D; Hodson EM; Craig JC
Pediatr Nephrol; 2003 Sep; 18(9):906-12. PubMed ID: 12836096
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[TBL] [Abstract][Full Text] [Related]
14. Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis.
Fu HD; Qian GL; Jiang ZY
J Investig Med; 2017 Jan; 65(1):65-71. PubMed ID: 27489255
[TBL] [Abstract][Full Text] [Related]
15. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis.
Liu J; Li X; Huang T; Xu G
Front Pharmacol; 2022; 13():917532. PubMed ID: 35959430
[No Abstract] [Full Text] [Related]
17. Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting.
Saiteja P; Deepthi B; Krishnasamy S; Sravani M; Krishnamurthy S
Pediatr Nephrol; 2024 Apr; 39(4):1149-1160. PubMed ID: 37947902
[TBL] [Abstract][Full Text] [Related]
18. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
19. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
Zhang X; Ji L; Yang L; Tang X; Qin W
Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study.
Prasad N; Manjunath R; Rangaswamy D; Jaiswal A; Agarwal V; Bhadauria D; Kaul A; Sharma R; Gupta A
Indian J Nephrol; 2018; 28(1):46-52. PubMed ID: 29515301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
